Pulmonx (LUNG) Non Operating Income (2019 - 2025)
Pulmonx (LUNG) reported Non Operating Income of $758000.0 for Q3 2025, up 477.11% year-over-year from $131343.1 in Q3 2024, and up 753.45% quarter-over-quarter from -$116000.0 in Q2 2025.
Pulmonx (LUNG) Non Operating Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Non Operating Income data on file, last reported at $758000.0 in Q3 2025.
- Non Operating Income for Q3 2025 came in at $758000.0, up 477.11% year-over-year; the trailing twelve-month figure through Sep 2025 was $886000.0 (up 597.75% YoY), and the FY2024 annual result was $256000.0, up 138.04% from the prior year.
- Non Operating Income climbed to $758000.0 in Q3 2025 per LUNG's latest filing, from -$116000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $758000.0 in Q3 2025 and troughed at -$432000.0 in Q3 2022.
- A 5-year average of -$32722.2 and a median of -$106000.0 in 2021 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income sank 277.61% in 2023, then surged 477.11% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$383000.0 in 2021, then soared by 152.48% to $201000.0 in 2022, then slumped by 277.61% to -$357000.0 in 2023, then jumped by 121.57% to $77000.0 in 2024, then surged by 884.42% to $758000.0 in 2025.
- Business Quant data shows LUNG's Non Operating Income at $758000.0 in Q3 2025, -$116000.0 in Q2 2025, and $167000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 758,000.00 |
| Jun 30, 2025 | -116,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | -201,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | 415,000.00 |
| Dec 31, 2023 | -357,000.00 |
| Sep 30, 2023 | -262,000.00 |
| Jun 30, 2023 | -162,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 201,000.00 |
| Sep 30, 2022 | -432,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Dec 31, 2021 | -383,000.00 |
| Sep 30, 2021 | -267,000.00 |
| Jun 30, 2021 | -96,000.00 |
| Mar 31, 2021 | 161,000.00 |
| Dec 31, 2020 | 230,000.00 |
| Sep 30, 2020 | 2.63 Mn |